https://soundcloud.com/bergscloud/
Music promoted by https://www.chosic.com/free-music/all/
Creative Commons CC BY-SA 3.0
https://creativecommons.org/licenses/by-sa/3.0/
NordVPN’s special deal
Posted in futurism
Don’t miss out on NordVPN’s special deal. Save big, get 2 years of protection, and be cybersafe 24/7.
Regulate AI Now
Posted in military, policy, robotics/AI
In the six months since FLI published its open letter calling for a pause on giant AI experiments, we have seen overwhelming expert and public concern about the out-of-control AI arms race — but no slowdown. In this video, we call for U.S. lawmakers to step in, and explore the policy solutions necessary to steer this powerful technology to benefit humanity.
The BBC has blocked the artificial intelligence software behind ChatGPT from accessing or using its content.
The move aligns the BBC with Reuters, Getty Images and other content providers that have taken similar steps over copyright and privacy concerns. Artificial intelligence can repurpose content, creating new text, images and more from the data.
Rhodri Talfan Davies, director of nations at the BBC said the BBC was taking steps to safeguard the interests of licence fee payers as this new technology evolves.
A New APT Emerges: Grayling, an unknown player, targets IT, manufacturing, and biomedical sectors in Taiwan. Researchers reveal their distinctive techniques in the latest report.
Read:
A team of researchers has found a way to speed up the creation of quantum entanglement, a mystifying property of quantum mechanics that Albert Einstein once described as “spooky action at a distance.”
The researchers behind the discovery include Kater Murch, the Charles M. Hohenberg Professor of Physics; Weijian Chen, a postdoctoral research associate in the Department of Physics; and Maryam Abbasi, a postdoctoral research associate in the Department of Chemistry. Their paper was featured on the cover of Physical Review Letters.
Entanglement has baffled researchers—and nearly everyone who has ever read about quantum physics —since Einstein and colleagues first proposed it in the 1930s.
In this October 13 Learning Lab, Hilary Sherman, a Senior Scientist in the Corning Life Sciences Applications Lab, and Robert Padilla, a Field Application Scientist at Corning, dive into the topic of 3D culture techniques and why these technologies should be a part of any researcher’s repertoire.
Three-dimensional (3D) cultures such as spheroids and organoids are an important part of the research model market, helping to close the gap between cell cultures and animal models. Both organoids and spheroids have been used to create in vivo-like tissue models of cancer subtypes to study novel therapies and to make models for tissue engineering and regenerative medicine studies. But there are some key differences, with important implications for various applications. The right tool for a project is not always obvious. For spheroids and organoids, knowing where the cultures are similar and where they differ will help scientists select the best resource for their projects the first time around.
🔒 Hackers are exploiting the CVE-2023–3519 vulnerability in Citrix NetScaler devices for credential harvesting attacks.
Patch your systems ASAP!
Heads up, Linux users! A new critical vulnerability in the libcue library exposes GNOME Linux systems to remote code execution (RCE) attacks.
Guidance and recommendations for prostate cancer screening have changed over the years. While there is no standard screening test, doctors may use a prostate-specific antigen (PSA) test to help diagnose prostate cancer. Doctors may follow a positive PSA test with a prostate biopsy.
Most recommending bodies emphasize a shared decision-making (SDM) approach for prostate cancer screening by PSA testing. This strategy moves away from doctors making treatment decisions and instead relies on collaborative interactions between patients and healthcare teams.
Why do expert opinions on prostate cancer screening differ? This remains a complex question with a lot to unpack. First, we have limited treatment options for cancer that has already spread outside of the prostate. Thus, detecting these cases will often not improve health or prolong life. Second, many cases of slow-growing prostate cancer will never become life-threatening; detection of these cases can be considered overdiagnosis and may lead to anxiety, unnecessary treatment, and accompanying side effects. Unnecessary biopsies, which provide no additional value to patients and physicians in decision-making, can also come with complications such as bleeding and infection.